Cite
HARVARD Citation
Kim, J. et al. (2023). Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. Journal of clinical oncology. 41 (4), pp. 871-880. [Online].